Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 2
1977 1
1979 6
1980 1
1981 1
1982 1
1983 3
1984 4
1986 4
1987 3
1989 6
1990 9
1991 2
1992 5
1993 6
1994 5
1995 1
1996 3
1997 4
1998 5
1999 4
2000 3
2001 4
2002 1
2003 1
2004 1
2005 2
2006 2
2007 3
2008 4
2009 1
2010 3
2011 9
2012 10
2013 14
2014 20
2015 10
2016 21
2017 21
2018 27
2019 24
2020 31
2021 1
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 29030465

261 results
Results by year
Filters applied: . Clear all
Page 1
Cluster Analysis Identifies Distinct Pathogenetic Patterns in C3 Glomerulopathies/Immune Complex-Mediated Membranoproliferative GN.
Iatropoulos P, Daina E, Curreri M, Piras R, Valoti E, Mele C, Bresin E, Gamba S, Alberti M, Breno M, Perna A, Bettoni S, Sabadini E, Murer L, Vivarelli M, Noris M, Remuzzi G; Registry of Membranoproliferative Glomerulonephritis/C3 Glomerulopathy; Nastasi. Iatropoulos P, et al. J Am Soc Nephrol. 2018 Jan;29(1):283-294. doi: 10.1681/ASN.2017030258. Epub 2017 Oct 13. J Am Soc Nephrol. 2018. PMID: 29030465 Free PMC article.
Unraveling the Molecular Mechanisms Underlying Complement Dysregulation by Nephritic Factors in C3G and IC-MPGN.
Donadelli R, Pulieri P, Piras R, Iatropoulos P, Valoti E, Benigni A, Remuzzi G, Noris M. Donadelli R, et al. Front Immunol. 2018 Oct 15;9:2329. doi: 10.3389/fimmu.2018.02329. eCollection 2018. Front Immunol. 2018. PMID: 30487789 Free PMC article.
Autoimmune abnormalities of the alternative complement pathway in membranoproliferative glomerulonephritis and C3 glomerulopathy.
Noris M, Donadelli R, Remuzzi G. Noris M, et al. Pediatr Nephrol. 2019 Aug;34(8):1311-1323. doi: 10.1007/s00467-018-3989-0. Epub 2018 Jun 9. Pediatr Nephrol. 2019. PMID: 29948306 Review.
Complement gene variants determine the risk of immunoglobulin-associated MPGN and C3 glomerulopathy and predict long-term renal outcome.
Iatropoulos P, Noris M, Mele C, Piras R, Valoti E, Bresin E, Curreri M, Mondo E, Zito A, Gamba S, Bettoni S, Murer L, Fremeaux-Bacchi V, Vivarelli M, Emma F, Daina E, Remuzzi G. Iatropoulos P, et al. Mol Immunol. 2016 Mar;71:131-142. doi: 10.1016/j.molimm.2016.01.010. Epub 2016 Feb 16. Mol Immunol. 2016. PMID: 26895476
C4 nephritic factor in patients with immune-complex-mediated membranoproliferative glomerulonephritis and C3-glomerulopathy.
Garam N, Prohászka Z, Szilágyi Á, Aigner C, Schmidt A, Gaggl M, Sunder-Plassmann G, Bajcsi D, Brunner J, Dumfarth A, Cejka D, Flaschberger S, Flögelova H, Haris Á, Hartmann Á, Heilos A, Mueller T, Rusai K, Arbeiter K, Hofer J, Jakab D, Sinkó M, Szigeti E, Bereczki C, Janko V, Kelen K, Reusz GS, Szabó AJ, Klenk N, Kóbor K, Kojc N, Knechtelsdorfer M, Laganovic M, Lungu AC, Meglic A, Rus R, Kersnik-Levart T, Macioniene E, Miglinas M, Pawłowska A, Stompór T, Podracka L, Rudnicki M, Mayer G, Romana Rysava, Reiterova J, Saraga M, Tomáš Seeman, Zieg J, Sládková E, Szabó T, Capitanescu A, Stancu S, Tisljar M, Galesic K, Tislér A, Vainumäe I, Windpessl M, Zaoral T, Zlatanova G, Csuka D. Garam N, et al. Orphanet J Rare Dis. 2019 Nov 8;14(1):247. doi: 10.1186/s13023-019-1237-8. Orphanet J Rare Dis. 2019. PMID: 31703608 Free PMC article.
Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies.
Servais A, Noël LH, Roumenina LT, Le Quintrec M, Ngo S, Dragon-Durey MA, Macher MA, Zuber J, Karras A, Provot F, Moulin B, Grünfeld JP, Niaudet P, Lesavre P, Frémeaux-Bacchi V. Servais A, et al. Kidney Int. 2012 Aug;82(4):454-64. doi: 10.1038/ki.2012.63. Epub 2012 Mar 28. Kidney Int. 2012. PMID: 22456601 Free article.
C5 Convertase Blockade in Membranoproliferative Glomerulonephritis: A Single-Arm Clinical Trial.
Ruggenenti P, Daina E, Gennarini A, Carrara C, Gamba S, Noris M, Rubis N, Peraro F, Gaspari F, Pasini A, Rigotti A, Lerchner RM, Santoro D, Pisani A, Pasi A, Remuzzi G; EAGLE Study Group. Ruggenenti P, et al. Am J Kidney Dis. 2019 Aug;74(2):224-238. doi: 10.1053/j.ajkd.2018.12.046. Epub 2019 Mar 28. Am J Kidney Dis. 2019. PMID: 30929851
Outcome of membranoproliferative glomerulonephritis and C3-glomerulopathy in children and adolescents.
Holle J, Berenberg-Goßler L, Wu K, Beringer O, Kropp F, Müller D, Thumfart J. Holle J, et al. Pediatr Nephrol. 2018 Dec;33(12):2289-2298. doi: 10.1007/s00467-018-4034-z. Epub 2018 Sep 20. Pediatr Nephrol. 2018. PMID: 30238151
C5 nephritic factors drive the biological phenotype of C3 glomerulopathies.
Marinozzi MC, Chauvet S, Le Quintrec M, Mignotet M, Petitprez F, Legendre C, Cailliez M, Deschenes G, Fischbach M, Karras A, Nobili F, Pietrement C, Dragon-Durey MA, Fakhouri F, Roumenina LT, Fremeaux-Bacchi V. Marinozzi MC, et al. Kidney Int. 2017 Nov;92(5):1232-1241. doi: 10.1016/j.kint.2017.04.017. Epub 2017 Jul 14. Kidney Int. 2017. PMID: 28712854
Hereditary and acquired complement dysregulation in membranoproliferative glomerulonephritis.
Licht C, Fremeaux-Bacchi V. Licht C, et al. Thromb Haemost. 2009 Feb;101(2):271-8. Thromb Haemost. 2009. PMID: 19190809 Review.
261 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback